Janssen Robert's Form 4 filing
Dynavax Technologies Corp (DVAX) · filed Jan 8, 2024
- Accession no.
- 0001209191-24-001195
- Filed
- Jan 8, 2024
- Trade date
- Jan 4, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $22.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Janssen RobertCIK 0001580849 | Officer (SVP and CMO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | Common Stock | MOption exerciseAcquired | +1,500 | $9.41 | +$14,115 | 51,425 | Direct | |
| Jan 4, 2024 | Common Stock | SSaleDisposed | −1,500 | $15.00 | −$22,500 | 49,925 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | Common Stock | MOption exerciseDisposed | −1,500 | –F3 | – | 38,673 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Not applicable.
Referenced by the price of 1 transaction in Table II.